SB
FMTX

Samsara BioCapital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Samsara BioCapital’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,065,413
Closed -$21.3M – 58
2022
Q3 		$21.3M Sell
1,065,413
-500,113
-32% -$6.6M 4.96% 5
2022
Q2 		$10.8M Hold
1,565,526
– – 2.88% 6
2022
Q1 		$14.6M Hold
1,565,526
– – 3.67% 7
2021
Q4 		$22.3M Hold
1,565,526
– – 4.32% 6
2021
Q3 		$36.3M Sell
1,565,526
-3
-0% -$71 5.7% 5
2021
Q2 		$39M Hold
1,565,529
– – 4.81% 6
2021
Q1 		$43.9M Buy
1,565,529
+147,000
+10% +$5.3M 8.09% 3
2020
Q4 		$49.5K Sell
1,418,529
-73,634
-5% -$3.21M 4.98% 4
2020
Q3 		$74.4M Sell
1,492,163
-86,225
-5% -$3.48M 20.74% 1
2020
Q2 		$73.4M Buy
+1,578,388
New +$68.4M 23.61% 1

Samsara BioCapital's FMTX Position: Q4 2022 in Review

Samsara BioCapital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,065,413 shares — an estimated $21.3M sold.

Samsara BioCapital first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $74.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Samsara BioCapital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Samsara BioCapital sold 1,065,413 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $21.3M.
  • Samsara BioCapital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Samsara BioCapital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $74.4M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Samsara BioCapital's 13F filing for Q4 2022, filed 14 Feb 2023.